Peptide record

TPDB10430

Antibacterial Anticancer Antifungal Antiparasitic Antiviral standard
24 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB10430
Antibacterial Anticancer Antifungal Antiparasitic Antiviral
Anti-infective peptides Cancer-related peptides
AntiBP3 dbAMP DRAMP Peptipedia AntiCP 2.0 iACP-DRLF AFP-GFuse Antifungipept CAFPdb
standard
No
A 24-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
FLPAVLLVATHVLPTVFCAITRKC
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C123H202N30O28S2
NDEQGMSWY
LV
2613.26
9.15
3
0
14
+2
-0.91
1.483
142.08
Mammalian: 1.1 hour Yeast: 3 min E.coli: 2 min
125
0.05
5
Residue Composition
number
3
A
1
R
0
N
0
D
2
C
0
E
0
Q
0
G
1
H
1
I
4
L
1
K
0
M
2
F
2
P
0
S
3
T
0
W
0
Y
4
V
Amino Acid Distribution
A: 3 R: 1 N: 0 D: 0 C: 2 E: 0 Q: 0 G: 0 H: 1 I: 1 L: 4 K: 1 M: 0 F: 2 P: 2 S: 0 T: 3 W: 0 Y: 0 V: 4
Chemical Descriptors
24 reviewed residue count
C123H202N30O28S2 sequence-only estimate (linear, free termini)
2613.26 sequence-only estimate (linear, free termini)
9.15 sequence-only estimate (linear, free termini)
+2 sequence-only estimate (linear, free termini)
-0.91 sequence-only estimate (linear, free termini)
1.483 sequence-only estimate (linear, free termini)
Evidence Records 12 records
Evidence 1 Activity

Activity

MIC
Antibacterial
3.4 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
Active against Gram- bacteria E. coli (MIC 3.4 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 27.2 ug/ml), Gram+ bacteria S. aureus (MIC
Evidence 2 Activity

Activity

MIC
Antibacterial
6.8 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP

Other

MIC 3.4 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 27.2 ug/ml), Gram+ bacteria S. aureus (MIC 6.8 ug/ml), and yeast C. albicans (MIC 6.8 ug/ml). Updated 7/2021
Evidence 3 Activity

Activity

MIC
Antibacterial
6.8 µg/mL

Target

Candida albicans

Source & Reference

dbAMP DRAMP

Other

lled P. aeruginosa) (MIC 27.2 ug/ml), Gram+ bacteria S. aureus (MIC 6.8 ug/ml), and yeast C. albicans (MIC 6.8 ug/ml). Updated 7/2021
Evidence 4 Activity

Activity

MIC
Antifungal
3.4 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
Active against Gram- bacteria E. coli (MIC 3.4 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 27.2 ug/ml), Gram+ bacteria S. aureus (MIC
Evidence 5 Activity

Activity

MIC
Antifungal
6.8 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

MIC 3.4 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 27.2 ug/ml), Gram+ bacteria S. aureus (MIC 6.8 ug/ml), and yeast C. albicans (MIC 6.8 ug/ml). Updated 7/2021
Evidence 6 Activity

Activity

MIC
Antifungal
6.8 µg/mL

Target

Candida albicans

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

lled P. aeruginosa) (MIC 27.2 ug/ml), Gram+ bacteria S. aureus (MIC 6.8 ug/ml), and yeast C. albicans (MIC 6.8 ug/ml). Updated 7/2021
Evidence 7 Activity

Activity

MIC
Antiparasitic
3.4 µg/mL

Target

Escherichia coli

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets.
Active against Gram- bacteria E. coli (MIC 3.4 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 27.2 ug/ml), Gram+ bacteria S. aureus (MIC
Evidence 8 Activity

Activity

MIC
Antiparasitic
6.8 µg/mL

Target

Staphylococcus aureus

Source & Reference

DRAMP

Other

MIC 3.4 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 27.2 ug/ml), Gram+ bacteria S. aureus (MIC 6.8 ug/ml), and yeast C. albicans (MIC 6.8 ug/ml). Updated 7/2021
Evidence 9 Activity

Activity

MIC
Antiparasitic
6.8 µg/mL

Target

Candida albicans

Source & Reference

DRAMP

Other

lled P. aeruginosa) (MIC 27.2 ug/ml), Gram+ bacteria S. aureus (MIC 6.8 ug/ml), and yeast C. albicans (MIC 6.8 ug/ml). Updated 7/2021
Evidence 10 Activity

Activity

MIC
Antiviral
3.4 µg/mL

Target

Escherichia coli

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiviral
DRAMP antiviral activity supported by activity records against viral targets.
Active against Gram- bacteria E. coli (MIC 3.4 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 27.2 ug/ml), Gram+ bacteria S. aureus (MIC
Evidence 11 Activity

Activity

MIC
Antiviral
6.8 µg/mL

Target

Staphylococcus aureus

Source & Reference

DRAMP

Other

MIC 3.4 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 27.2 ug/ml), Gram+ bacteria S. aureus (MIC 6.8 ug/ml), and yeast C. albicans (MIC 6.8 ug/ml). Updated 7/2021
Evidence 12 Activity

Activity

MIC
Antiviral
6.8 µg/mL

Target

Candida albicans

Source & Reference

DRAMP

Other

lled P. aeruginosa) (MIC 27.2 ug/ml), Gram+ bacteria S. aureus (MIC 6.8 ug/ml), and yeast C. albicans (MIC 6.8 ug/ml). Updated 7/2021